An oral JAK inhibitor, Leqselvi interrupts the pathways thought to contribute to hair loss in severe alopecia areata, according to Sun.
Encouraged by the potential of the weight-loss candidates acquired from Carmot Therapeutics, Roche will speed up the development of its obesity programs, seeking to differentiate itself in the market.
The FDA’s Oncologic Drugs Advisory Committee strongly supports changing clinical trials for non-small cell lung cancer drugs given in the perioperative setting, pointing out the need for a more nuanced approached to treatments before and after surgery.
The vaccine, branded Arexvy, was approved by the U.S. Food and Drug Administration in June but the Centers for Disease Control and Prevention (CDC) did not recommend RSV shots for adults under 60 years.
The drugmaker posted better-than-expected second-quarter results, driven by growth from new products like anemia treatment Reblozyl and heart drug Camzyos as well as from its top-seller, blood thinner Eliquis.
The European Union’s drugs regulator has rejected Eisai and Biogen’s breakthrough treatment for early Alzheimer’s disease, it said on Friday, in a blow to the drugmakers as take-up in the U.S. has been slower than expected.